25 research outputs found

    Di-μ2-bromido-bis­[bromido(η6-1,2,4,5-tetra­methyl­benzene)ruthenium(II)]

    Get PDF
    The asymmetric unit of the title compound, [Ru2Br4(C10H14)2], contains one half of the centrosymmetric mol­ecule. Each Ru center is coordinated by tetra­methyl­benzene ring in a η6-coordination mode, and one terminal and two bridging bromine atoms. The aromatic rings and the Ru2Br2 four-membered ring form a dihedral angle of 55.99 (8)°. In the crystal structure, weak inter­molecular C—H⋯Br inter­actions link mol­ecules into chains propagated in [001]

    Di-μ2-chlorido-bis­[chlorido(η6-hexa­methyl­benzene)ruthenium(II)]

    Get PDF
    Dimeric mol­ecules of the title compound, [Ru2Cl4(C12H18)2], are located on a crystallographic centre of inversion with one mol­ecule in the asymmetric unit. The hexa­methyl­benzene rings are in an η6-coordination to the ruthenium centres, which are bridged by two chloride ligands. In addition, the ruthenium centres are bonded to another chloride ligand. The aromatic rings and the Ru2Cl2 four-membered ring enclose a dihedral angle of 55.85 (6)°

    Targeting of the intracellular redox balance by metal complexes towards anticancer therapy.

    No full text
    International audienceThe development of cancers is often linked to the alteration of essential redox processes, and therefore, oxidoreductases involved in such mechanisms can be considered as attractive molecular targets for the development of new therapeutic strategies. On the other hand, for more than two decades, transition metals derivatives have been leading the research on drugs as alternatives to platinum-based treatments. The success of such compounds is particularly due to their attractive redox kinetics properties, favorable oxidation states, as well as routes of action different to interactions with DNA, in which redox interactions are crucial. For instance, the activity of oxidoreductases such as PHD2 (prolyl hydroxylase domain-containing protein) which can regulate angiogenesis in tumors, LDH (lactate dehydrogenase) related to glycolysis, and enzymes, such as catalases, SOD (superoxide dismutase), TRX (thioredoxin) or GSH (glutathione) involved in controlling oxidative stress, can be altered by metal effectors. In this review, we wish to discuss recent results on how transition metal complexes have been rationally designed to impact on redox processes, in search for effective and more specific cancer treatments

    Recent Advances on O-Ethoxycarbonyl and O-Acyl Protected Cyanohydrins

    No full text
    Ethoxycarbonyl cyanohydrins and O-acyl cyanohydrins are examples of O-protected cyanohydrins in which the protecting group presents an electrophilic center, contributing to additional reaction pathways. The first section of this review describes recent advances on the synthesis of O-ethoxycarbonyl and O-acyl protected cyanohydrins. Reactions using KCN or alkyl cyanoformates as the cyanide ion source are described, as well as organic and transition metal catalysis used in their preparation, including asymmetric cyanation. In a second part, transformations, and synthetic applications of O-ethoxycarbonyl/acyl cyanohydrins are presented. A variety of structures has been obtained starting from such protected cyanohydrins and, in particular, the synthesis of oxazoles, 1,4-diketones, 1,3-diketones, 2-vinyl-2-cyclopentenones through various methods are discussed

    Tandem Michael addition–Claisen-type condensation of anions of <i>O</i>-ethyl carbonates of cyanohydrins to cyclohex-2-en-1-one

    No full text
    <p>A one pot method for the synthesis of ethyl 2-acetoxy-6-aroylcyclohex-1-ene-1-carboxylates and ethyl 2-acetoxy-6-heterocarbonylcyclohex-1-ene-1-carboxylates through Michael addition of the anions of ethyl carbonates of cyanohydrins to cyclohex-2-en-1-one and subsequent reaction with acetic anhydride is described. These compounds are potential intermediates for the synthesis of 9,10-anthraquinone and heterofused 1,4-naphthoquinone derivatives.</p

    Synthesis, Structural Characterization, and In Vitro and In Silico Antifungal Evaluation of Azo-Azomethine Pyrazoles (PhN2(PhOH)CHN(C3N2(CH3)3)PhR, R = H or NO2)

    Get PDF
    The azo-azomethine imines, R1-N=N-R2-CH=N-R3, are a class of active pharmacological ligands that have been prominent antifungal, antibacterial, and antitumor agents. In this study, four new azo-azomethines, R1 = Ph, R2 = phenol, and R3 = pyrazol-Ph-R’ (R = H or NO2), have been synthesized, structurally characterized using X-ray, IR, NMR and UV–Vis techniques, and their antifungal activity evaluated against certified strains of Candida albicans and Cryptococcus neoformans. The antifungal tests revealed a high to moderate inhibitory activity towards both strains, which is regulated as a function of both the presence and the location of the nitro group in the aromatic ring of the series. These biological assays were further complemented with molecular docking studies against three different molecular targets from each fungus strain. Molecular dynamics simulations and binding free energy calculations were performed on the two best molecular docking results for each fungus strain. Better affinity for active sites for nitro compounds at the “meta” and “para” positions was found, making them promising building blocks for the development of new Schiff bases with high antifungal activity.Fil: Fernandez, Dorancelly. Universidad del Quindío. Programa de Química. Laboratorio de Química Inorgánica y Catálisis; Colombia.Fil: Restrepo-Acevedo, Andrés. Universidad Nacional Autónoma de México. Instituto de Química; México.Fil: Rocha-Roa, Cristian. Universidad del Quindío. Centro de Investigaciones Biomédicas. Grupo GEPAMOL; Colombia.Fil: Rocha-Roa, Cristian. Universidad de Antioquia. Biophysics of Tropical Diseases. Max Planck Tandem Group; Colombia.Fil: Le Lagadec, Ronan. Universidad Nacional Autónoma de México. Instituto de Química; México.Fil: Abonia, Rodrigo. Universidad del Valle. Departamento de Química; Colombia.Fil: Zacchino, Susana. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Área Farmacognosia; Rosario.Fil: Gómez Castaño, Jovanny A. Universidad Pedagógica y Tecnológica de Colombia. Facultad de Ciencias. rupo Química-Física Molecular y Modelamiento Computacional (QUIMOL®); Colombia.Fil: Cuenú-Cabezas, Fernando. Universidad del Quindío. Programa de Química. Laboratorio de Química Inorgánica y Catálisis; Colombia

    Synthesis, Properties, and Electrochemistry of bis(iminophosphorane)pyridine Iron(II) Pincer Complexes

    No full text
    Iron derivatives have emerged as valuable catalysts for a variety of transformations, as well as for biological and photophysical applications, and iminophosphorane can be considered an ideal ligand scaffold for modulating electronic and steric parameters in transition metal complexes. In this report, we aimed to synthesize dichloride and dibromide iron(II) complexes supported by symmetric bis(iminophosphorane)pyridine ligands, starting from readily available ferrous halides. The ease of synthesis of this class of ligands served to access several derivatives with distinct electronic and steric properties imparted by the phosphine moiety. The ligands and the resulting iron(II) complexes were characterized by 31P and 1H NMR spectroscopy and DART or ESI mass spectrometry. While none of these iron(II) complexes could be characterized by single-crystal X-ray diffraction, suitable crystals of a µ-O bridged dinuclear iron complex bearing an iminophosphorane ligand were obtained, confirming a κ3 binding motif. The bis(iminophosphorane)pyridine ligands in the obtained iron(II) complexes are labile, as demonstrated by their facile substitution by terpyridine. Cyclic voltammetry studies revealed that the oxidation of bis(iminophosphorane)pyridine iron(II) complexes to iron(III) species is quasi-reversible, suggesting the strong thermodynamic stabilization of the iron(III) center imparted by the σ-donating iminophosphorane ligands
    corecore